Arrakis Therapeutics Investors

30 investors on Angel Roster list Arrakis Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series A and the largest groups are based in the United States, Switzerland and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Arrakis Therapeutics can appear together.

Investors listed
30
With verified email
57%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 30 Arrakis Therapeutics investors

The most complete profiles first. Showing 30 of 30.

  • Annie MitsakVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Eric YoungVerified

    Venture Capital, Founder, Investor · United Kingdom

    SeedSeries BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Filanet, Hallo and 85 more

    Verified email available

  • Guy RussoVerified

    Venture Capital, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Jared NewmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Joydeep BhattacharyyaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: BoostUp.ai, Node, OncoResponse, Hallo and 84 more

    Verified email available

  • Laura ChauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Louis BernemanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Manny StockmanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Richard GasterVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Robert AdelsonVerified

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more

    Verified email available

  • Tim ShannonVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 83 more

    Verified email available

  • AnneVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Anurag AgarwalVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • David PezeshkiVerified

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Hootan RashidifardVerified

    Venture Capital · United States

    AdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Matt CohenVerified

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Paulina HillVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Aaron Royston, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more

    Contact details available

  • Francesco Draetta

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Jaume Pons

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Katie Kerfoot

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Marc Singer

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more

    Contact details available

  • Michelle Doig

    Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Nandu Anilal

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Rayfe Gaspar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Thomas Lips

    Venture Capital, Private Equity Firm, Investor · Switzerland

    SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Black Diamond Therapeutics, Blueprint Medicines, TRACON Pharmaceuticals, Jounce Therapeutics and 30 more

    Contact details available

  • William Harrington

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more

    Contact details available

  • Yvonne Yamanaka

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Byron Ling

    Venture Capital · United States

    AdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Kirsten Leute

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Arrakis Therapeutics investors are on Angel Roster?

Angel Roster lists 30 Arrakis Therapeutics investors. 17 of them (57%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (29), Private Equity Firms (16) and University Program Investors (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Arrakis Therapeutics investors invest in?

Among those that list a stage, the most common are Series A (13), Series B (12) and Seed (6).

Where are Arrakis Therapeutics investors based?

Most are based in the United States (27), Switzerland (1) and the United Kingdom (1).

Which companies have Arrakis Therapeutics investors backed?

The most-backed portfolio companies among them are Hyalex Orthopaedics (18), Stargazer Pharmaceuticals (15), Beam Therapeutics (14), Precision BioSciences (13) and Checkmate Pharmaceuticals (11).

How do I contact Arrakis Therapeutics investors?

Create a free Angel Roster account to search and filter all 30, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.